Viatris (VTRS) announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus, or SLE. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results